F. Markus Leweke
F. Markus Leweke
Professor and Chair in Youth Depression Studies, Brain & Mind Centre, University of Sydney
Verified email at cimh.de - Homepage
Title
Cited by
Cited by
Year
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
FM Leweke, D Piomelli, F Pahlisch, D Muhl, CW Gerth, C Hoyer, ...
Translational psychiatry 2 (3), e94-e94, 2012
7272012
Elevated endogenous cannabinoids in schizophrenia
FM Leweke, A Giuffrida, U Wurster, HM Emrich, D Piomelli
Neuroreport 10 (8), 1665-1669, 1999
5151999
Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms
A Giuffrida, FM Leweke, CW Gerth, D Schreiber, D Koethe, J Faulhaber, ...
Neuropsychopharmacology 29 (11), 2108-2114, 2004
5002004
Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology
OD Howes, R McCutcheon, O Agid, A De Bartolomeis, NJM Van Beveren, ...
American Journal of Psychiatry 174 (3), 216-229, 2017
3542017
Metabolic profiling of CSF: evidence that early intervention may impact on disease progression and outcome in schizophrenia
E Holmes, TM Tsang, JTJ Huang, FM Leweke, D Koethe, CW Gerth, ...
PLoS medicine 3 (8), e327, 2006
2972006
Towards a cannabinoid hypothesis of schizophrenia: cognitive impairments due to dysregulation of the endogenous cannabinoid system
HM Emrich, FM Leweke, U Schneider
Pharmacology Biochemistry and Behavior 56 (4), 803-807, 1997
2751997
Antibodies to infectious agents in individuals with recent onset schizophrenia
FM Leweke, CW Gerth, D Koethe, J Klosterkötter, I Ruslanova, ...
European archives of psychiatry and clinical neuroscience 254 (1), 4-8, 2004
2442004
Identification of a biological signature for schizophrenia in serum
E Schwarz, PC Guest, H Rahmoune, LW Harris, L Wang, FM Leweke, ...
Molecular psychiatry 17 (5), 494-502, 2012
2312012
Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: impact of cannabis use
FM Leweke, A Giuffrida, D Koethe, D Schreiber, BM Nolden, L Kranaster, ...
Schizophrenia research 94 (1-3), 29-36, 2007
2302007
Cannabis and psychiatric disorders: it is not only addiction
FM Leweke, D Koethe
Addiction biology 13 (2), 264-275, 2008
2232008
Disease biomarkers in cerebrospinal fluid of patients with first-onset psychosis
JTJ Huang, FM Leweke, D Oxley, L Wang, N Harris, D Koethe, CW Gerth, ...
PLoS Med 3 (11), e428, 2006
1922006
PRECLINICAL STUDY: acute and chronic cannabinoid treatment differentially affects recognition memory and social behavior in pubertal and adult rats
M Schneider, E Schömig, FM Leweke
Addiction biology 13 (3‐4), 345-357, 2008
1912008
Different effects of nabilone and cannabidiol on binocular depth inversion in man
FM Leweke, U Schneider, M Radwan, E Schmidt, HM Emrich
Pharmacology Biochemistry and Behavior 66 (1), 175-181, 2000
1882000
Validation of a blood-based laboratory test to aid in the confirmation of a diagnosis of schizophrenia
E Schwarz, R Izmailov, M Spain, A Barnes, JP Mapes, PC Guest, ...
Biomarker Insights 5, BMI. S4877, 2010
1822010
Expression of CB1 cannabinoid receptor in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression
D Koethe, IC Llenos, JR Dulay, C Hoyer, EF Torrey, FM Leweke, S Weis
Journal of neural transmission 114 (8), 1055, 2007
1802007
Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations
European Network of National Networks studying Gene-Environment Interactions ...
Schizophrenia Bulletin 40 (4), 729-736, 2014
1762014
Anandamide elevation in cerebrospinal fluid in initial prodromal states of psychosis
D Koethe, A Giuffrida, D Schreiber, M Hellmich, F Schultze-Lutter, ...
The British Journal of Psychiatry 194 (4), 371-372, 2009
1742009
Comorbid anxiety and affective disorder in alcohol-dependent patients seeking treatment: the first Multicentre Study in Germany
U Schneider, A Altmann, M Baumann, J Bernzen, B Bertz, U Bimber, ...
Alcohol and alcoholism 36 (3), 219-223, 2001
1652001
Gastrointestinal inflammation and associated immune activation in schizophrenia
EG Severance, A Alaedini, S Yang, M Halling, KL Gressitt, CR Stallings, ...
Schizophrenia research 138 (1), 48-53, 2012
1642012
Discordant patterns of bacterial translocation markers and implications for innate immune imbalances in schizophrenia
EG Severance, KL Gressitt, CR Stallings, AE Origoni, S Khushalani, ...
Schizophrenia research 148 (1-3), 130-137, 2013
1582013
The system can't perform the operation now. Try again later.
Articles 1–20